Retrospective review of GCT cutoff value based on pre-pregnancy BMI class in patients with GDM
Kajal Angras1, Victoria Boyd1, Amanda J Young2
1Women's Health Service Line, Division of Maternal-Fetal Medicine, Geisinger, Danville, PA, USA.
Insights
The glucose challenge test (GCT) cutoff value of 130 mg/dL effectively screens for gestational diabetes mellitus (GDM) across all pre-pregnancy BMI categories. This standardized cutoff ensures high sensitivity for GDM detection, simplifying screening protocols.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Gestational diabetes mellitus (GDM) is a significant pregnancy complication.
- Current screening protocols for GDM often involve a glucose challenge test (GCT).
- The optimal GCT cutoff value for GDM screening may vary based on pre-pregnancy body mass index (BMI).
Purpose of the Study:
- To determine the optimal glucose challenge test (GCT) cutoff value for screening gestational diabetes mellitus (GDM).
- To evaluate if pre-pregnancy BMI influences the optimal GCT cutoff value for GDM prediction.
- To establish a standardized GCT cutoff for GDM screening across diverse BMI categories.
Main Methods:
- Retrospective cohort analysis of singleton pregnancies (2004-2020) at a tertiary healthcare center.
- Utilized the first GCT value obtained between 20-32 weeks gestation.
- Employed receiver operator curve (ROC) analysis and Youden Index to identify optimal GCT cutoff values for each BMI category.
Main Results:
- A total of 23,550 patients were analyzed, with a GDM diagnosis rate of 7.1%.
- Optimal GCT cutoff values ranged from 130 mg/dL to 133 mg/dL across different BMI categories (normal, overweight, and obese classes I-III).
- Area Under the Curve (AUC) values, indicating predictive accuracy, ranged from 0.88 to 0.92 across BMI groups.
Conclusions:
- The study supports a universal GCT cutoff value of 130 mg/dL for GDM screening.
- This cutoff demonstrated high sensitivity (≥93%) across all pre-pregnancy BMI categories.
- A standardized GCT cutoff simplifies GDM screening protocols without compromising diagnostic accuracy.
Objectives:
To determine the optimal glucose challenge test (GCT) cutoff value for the screening of gestational diabetes mellitus (GDM) based on pre-pregnancy BMI.
Methods:
An-IRB approved retrospective cohort analysis of singleton pregnancies at a large tertiary healthcare center from January 2004 to December 2020 was performed. The first GCT value completed between 20 and 32 weeks was used. Using a receiver operator curve (ROC), we sought to determine the optimal GCT cutoff value for each BMI category that would predict the development of GDM. Youden Index was used to determine optimal cut-point of GCT values for each BMI class.
Results:
A total of 23,550 patients with a GCT value were identified. Of those, 1,676 (7.1%) were diagnosed with GDM. 513 (30.6%) with normal BMI, 449 (26.8%) overweight, 347 (20.7%) class I obese, 210 (12.5%) class II obese, and 157 (9.4%) class III obese patients were diagnosed with GDM. Gestational diabetes was predicted at GCT cutoff value of 130 mg/dL with an area under the curve (AUC) of 0.92 (BMI <25), 131 mg/dL with an AUC of 0.92 (overweight BMI), 131 mg/dL with an AUC of 0.89 (class I BMI), 133 mg/dL with an AUC of 0.88 (class II BMI), and 131 mg/dL with an AUC of 0.88 (class III BMI).
Conclusions:
AUC ranged from 0.88 to 0.92 with 93% or greater sensitivity for GCT cutoff value across each of the BMI categories. The findings support a GCT cutoff value of 130 mg/dL for GDM screening regardless of BMI.
More Related Videos
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
